Concepedia

Marta Bralic

MB

Statistics

Publications

1

Citations

76

H-Index

1

Active since

2018

Affiliations

United States Food and Drug Administration(Current)

Marta Bralic is an author at United States Food and Drug Administration specializing in anaplastic lymphoma kinase inhibition, lung cancer pharmacotherapy, and programmed cell death protein 1 inhibitors.

Publications per year

2018–2018

1

Publications

1

Real-World Outcomes of Patients with Metastatic Non-Small Cell Lung Cancer Treated with Programmed Cell Death Protein 1 Inhibitors in the Year Following U.S. Regulatory Approval

Sean Khozin, Kenneth R. Carson, Jizu Zhi et al. · The Oncologist · 2018 · 76 citations · Full text

, , +17

1–1 of 1